120 related articles for article (PubMed ID: 10686779)
1. [The role of alpha-interferon therapy in chronic myeloid leukemia].
Udvardy M
Orv Hetil; 2000 Jan; 141(2):67-70. PubMed ID: 10686779
[TBL] [Abstract][Full Text] [Related]
2. [The effectiveness of interferon-alpha therapy in Ph-positive chronic myeloid leukemia].
Bogdanov KV; Frolova OI; Marinets OV; Ogorodnikova IuS; Afanas'ev BV; Zaritskiĭ AIu
Vopr Onkol; 2003; 49(2):189-92. PubMed ID: 12785203
[TBL] [Abstract][Full Text] [Related]
3. [Alpha interferon in children with Philadelphia chromosome-positive chronic myeloid-leukaemia].
Ben Lakhal R; Aissaoui L; Jeddi R; Ayari B; Ben Abid H; Belhadj Ali Z; Gouider E; Meddeb B; Hafsia R; Hafsia A
Tunis Med; 2005 May; 83(5):296-9. PubMed ID: 16044905
[TBL] [Abstract][Full Text] [Related]
4. The role of interferon-alpha in the treatment of chronic myeloid leukemia.
Kujawski LA; Talpaz M
Cytokine Growth Factor Rev; 2007; 18(5-6):459-71. PubMed ID: 17703986
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha and cytosine arabinoside therapy in chronic myeloid leukemia.
Ezaki K
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():279-84. PubMed ID: 10895166
[No Abstract] [Full Text] [Related]
6. Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data.
Kantarjian HM; O'Brien S; Cortes J; Giles FJ; Rios MB; Shan J; Faderl S; Garcia-Manero G; Ferrajoli A; Verstovsek S; Wierda W; Keating M; Talpaz M
Cancer; 2003 Dec; 98(12):2636-42. PubMed ID: 14669283
[TBL] [Abstract][Full Text] [Related]
7. Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results.
Kantarjian HM; Talpaz M; O'Brien S; Smith TL; Giles FJ; Faderl S; Thomas DA; Garcia-Manero G; Issa JP; Andreeff M; Kornblau SM; Koller C; Beran M; Keating M; Rios MB; Shan J; Resta D; Capdeville R; Hayes K; Albitar M; Freireich EJ; Cortes JE
Clin Cancer Res; 2002 Jul; 8(7):2177-87. PubMed ID: 12114418
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myeloid leukaemia.
Galesic K; Bozic B; Racic I; Scukanec-Spoljar M
Nephrology (Carlton); 2006 Feb; 11(1):49-52. PubMed ID: 16509932
[TBL] [Abstract][Full Text] [Related]
9. Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia.
Heimpel H; Allan NC; Baccarani M; Guilhot F; Hehlmann R; Horowitz M; Kluin-Nelemans J; Schaefer U; Storb R; Thaler J
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S39. PubMed ID: 8769699
[No Abstract] [Full Text] [Related]
10. [Comparative efficiency of conventional myelosuppressive chemotherapy and therapy including interferon alpha in patients with chronic myeloid leukemia].
Volkova SA; Prytkova MV; Borovkov NN
Klin Med (Mosk); 2004; 82(3):45-50. PubMed ID: 15114775
[TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term culture.
Schultheis B; Heissig B; Pasternak G; Hörner S; Hehlmann R
Folia Biol (Praha); 2000; 46(6):251-5. PubMed ID: 11140858
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of chronic myeloid leukemia with interferon-alpha].
Szomor A; Molnár L; Nagy A; Dávid M; Alizadeh H; Kecskés M; Vidra T; Kereskai L; Pajor L; Losonczy H
Orv Hetil; 2000 Nov; 141(48):2601-4. PubMed ID: 11141958
[TBL] [Abstract][Full Text] [Related]
13. Interferon therapy in chronic myelogenous leukemia.
Guilhot F; Roy L; Guilhot J; Millot F
Hematol Oncol Clin North Am; 2004 Jun; 18(3):585-603, viii. PubMed ID: 15271394
[TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha therapy for chronic myeloid leukemia during pregnancy.
Regierer AC; Schulz CO; Kuehnhardt D; Flath B; Possinger K
Am J Hematol; 2006 Feb; 81(2):149-50. PubMed ID: 16432865
[No Abstract] [Full Text] [Related]
15. Interferon-alpha lymphoblastoid in chronic myeloid leukemia patients unresponsive to recombinant IFN alpha 2.
Steegmann JL; Granados E; Peñarrubia MJ
Haematologica; 1997; 82(6):731-2. PubMed ID: 9580090
[No Abstract] [Full Text] [Related]
16. [Treatment with interferon alpha of the lymphoblastic transformation of chronic myeloid leukemia].
Canales MA; Martínez J; Quevedo E; Hernández-Navarro F
Sangre (Barc); 1999 Dec; 44(6):493-4. PubMed ID: 10822770
[No Abstract] [Full Text] [Related]
17. [Hematologic and cytogenetic response to treatment in patients with chronic myeloid leukemia].
Tóthová E; Fricová M; Stecová N; Kafková A; Mudronová B; Svorcová E; Guman T; Raffac S; Hlebasková M
Cas Lek Cesk; 2000 Jul; 139(14):437-9. PubMed ID: 11048406
[TBL] [Abstract][Full Text] [Related]
18. A note on nucleoli in granulocytic precursors of the granulopoietic proliferating compartment in patients suffering from the chronic phase of chronic myeloid leukemia treated with two different drugs with different mode of action.
Smetana K; Jirásková I; Klamová H
Neoplasma; 1999; 46(5):295-8. PubMed ID: 10665845
[TBL] [Abstract][Full Text] [Related]
19. [Effectiveness of treatment with native alpha-interferon (Wellferon) in patients with chronic myeloid leukemia].
Rukavitsyn OA
Vopr Onkol; 1997; 43(6):606-9. PubMed ID: 9479361
[No Abstract] [Full Text] [Related]
20. [Molecular biology follow-up of interferon therapy in patients with chronic myeloid leukemia].
Iványi JL; Marton E; Kereskai L; Kiss Z; Pajor L
Orv Hetil; 2000 Nov; 141(47):2527-33. PubMed ID: 11143285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
